Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 40.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 40.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 32.5 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 2.0 | BCD100624C013 | 28.5 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 36.2 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 39.3 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 42.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 44.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 0.0 | BCD100624C001 | 36.4 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 0.5 | BCD100624C003 | 36.6 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 1.0 | BCD100624C007 | 49.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 2.0 | BCD100624C011 | 52.3 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 4.0 | BCD100624C015 | 47.3 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 8.0 | BCD100624C019 | 42.5 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 12.0 | BCD100624C023 | 45.9 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 24.0 | BCD100624C027 | 53.9 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 31.9 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | 31.3 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 36.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 26.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 36.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 42.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 47.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 0.5 | BCD100624C004 | 47 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 1.0 | BCD100624C008 | 45.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 2.0 | BCD100624C012 | 40.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 4.0 | BCD100624C016 | 40.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 8.0 | BCD100624C020 | 46.9 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 12.0 | BCD100624C024 | 40.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 24.0 | BCD100624C028 | 45.9 | pmol/sample |